2,589
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Inhibition behaviours of some phenolic acids on rat kidney aldose reductase enzyme: an in vitro study

, , &
Pages 277-284 | Received 07 Mar 2016, Accepted 11 Oct 2016, Published online: 22 Jan 2017

References

  • International Diabetes Federation. Diabetes Atlas. 6th ed.; 2013. Available from: http://www.idf.org/diabetesatlas.
  • World Health Organization. The top ten causes of death. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/#.
  • Reddy TN, Ravinder M, Bagul P, et al. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors(ARIs). Eur J Med Chem 2014;71:53–66.
  • Alım Z, Beydemir Z. Effects of some anti-neoplastic drugs on sheep liver sorbitol dehydrogenase. Arch Physiol Biochem 2012;118:244–52.
  • Cheng HM, Gonzalez RG. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis. Metab Clin Exp 1986;35:10–14.
  • Koya D, Haneda M, Kikkawa R, et al. D-α-Tocopherol treatment prevents glomerular dysfunctions in diabetic rats through inhibition of proteinkinase C-diacylglycerol pathway. Biofactors 1998;7:69–76.
  • Patel DK, Kumar R, Sairam K, Hemalatha S. Pharmacologically tested aldose reuctase inhibitors isolated from plant sources-A concise report. Chin J Nat Med 2012;10:388–40.
  • Morre DM, Lenaz G, Morre DJ. Surface oxidase and oxidative stress propagation in aging. J Exp Biol 2000;203:1513–21.
  • Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992;15:1835–43.
  • Hamada Y, Araki N, Horiuchi S, et al. Role of poliol pathway in nonenzymatic glycation. Nephrol Dial Transplant 1996;11:5–95.
  • Israël M, Schwartz L. On the metabolic origin of cancer: substances that target tumor metabolism. Biomed Res 2011;22:130–64.
  • Pfeifer MA, Schumer MP, Gelber DA. Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes 1997;46:82–9.
  • Akileshwari C, Raghu G, Muthenna P, et al. Bioflavonoid ellagic acid inhibits aldose reductase: Implications for prevention of diabetic complications. J Funct Foods 2014;6:374–83.
  • Suryanarayana P, Kumar PA, Saraswat M, et al. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol Vis 2004;10:148–54.
  • Saraswat M, Muthenna P, Suryanarayana P, et al. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Asia Pac J Clin Nutr 2008;17:558–65.
  • Akileshwari C, Muthenna P, Nastasijevic B, et al. Inhibition of aldose reductase by Gentiana lutea extracts. Exp Diabetes Res 2012;2012:147965. doi: 10.1155/2012/147965.
  • Muthenna P, Akileshwari C, Reddy GB. Ellagic acid, a new antiglycating agent: its inhibition of Nε-(carboxymethyl)lysine. Biochem J 2012;442:221–30.
  • Chethan S, Dharmesh SM, Malleshi NG. Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols. Bioorg Med Chem 2008;16:10085–90.
  • Güvenç A, Okada Y, Akkol EK, et al. Investigations of anti-inflammatory, antinociceptive, antioxidant and aldose reductase inhibitory activities of phenolic compounds from Sideritis brevibracteata. Food Chem 2010;118:686–92.
  • Jung HA, Nurul IMD, Kwon YS, et al. Extraction and identification of three major aldose reductase inhibitors from Artemisia montana. Food Chem Toxicol 2011;49:376–84.
  • Dongare V, Kulkarni C, Kondawar M, et al. Inhibition of aldose reductase and anti-cataract action of trans-anethole isolated from Foeniculum vulgare Mill. fruits. Food Chem 2012;132:385–90.
  • Ha TJ, Lee JH, Lee MH, et al. Isolation and identification of phenolic compounds from the seeds of Perilla frutescens (L.) and their inhibitory activities against α-glucosidase and aldose reductase. Food Chem 2012;135:1397–403.
  • Mok SY, Lee S. Identification of flavonoids and flavonoid rhamnosides from Rhododendron mucronulatum for. Albiflorum and their inhibitory activities against aldose reductase. Food Chem 2013;136:969–74.
  • Chen SC, Chung KT. Mutagenicity and antimutagenicity studies of tannic acid and its related compounds. Food Chem Toxicol 2000;38:1–5.
  • Gülçin I, Huyut Z, Elmastas M, et al. Radical scavenging and antioxidant activity of tannic acid. Arab J Chem 2010;3:43–53.
  • Farah A, Monteiro M, Donangelo CM, et al. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr 2008;138:2309–15.
  • Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002;156:445–53.
  • Salazar-Martinez E, Willett WC, Ascherio A, et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004;140:1–8.
  • Ranheim T, Halvorsen B. Coffee consumption and human health-beneficial or detrimental?-Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 2005;49:274–84.
  • Niciforovic N, Abramovic H. Sinapic acid and its derivatives: natural sources and bioactivity. Compr Rev Food Sci F 2014;13:34–51.
  • Engels C, Schieber A, Ganzle MG. Sinapic acid derivatives in defatted oriental mustard (Brassica juncea L.) seed meal extracts using UHPLC-DADESI- MSn and identification of compounds with antibacterial activity. Eur Food Res Technol 2012;234:535–42.
  • Yun KJ, Koh DJ, Kim SH, et al. Anti-inflammatory effects of sinapic acid through the suppression of inducible nitric oxide synthase, cyclooxygase-2, and proinflammatory cytokines expressions via nuclear factor-κB inactivation. J Agric Food Chem 2008;56:10265–72.
  • Hudson EA, Dinh PA, Kokubun T, et al. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev 2000;9:1163–70.
  • Yoon BH, Jung JW, Lee JJ, et al. Anxiolytic-like effects of sinapic acid in mice. Life Sci 2007;81:234–40.
  • Kakkar S, Bais S. A review on protocatechuic acid and its pharmacological potential. ISRN Pharmacol 2014;2014:952943. doi: http://dx.doi.org/10.1155/2014/952943.
  • Er M, Degirmencioglu I, Tahtacı H. Novel olefinic-centered macroacyclic compounds involving tetrasubstituted 4-hydroxybenzoic acid fragments: synthesis, structural characterization and comparison of experimental and computational results. Spectrochimica Acta Part a: Mol Biomol Spectrosc 2015;139:68–74.
  • Zang LY, Cosma G, Gardner H, et al. Effect of antioxidant protection by p-coumaric acid on low-density lipoprotein cholesterol oxidation. Am J Physiol Cell Physiol 2000;279:954–60.
  • Paiva LB, Goldbeck R, Santos WD, et al. Ferulic acid and derivatives: molecules with potential application in the pharmaceutical field. Braz J Pharm Sci 2013;49:395–411.
  • Gitzinger M, Kemmer C, Fluri DA, et al. The food additive vanillic acid controls transgene expression in mammalian cells and mice. Nucleic Acids Res 2012;40:5.
  • Srinivasan S, Muthukumaran J, Muruganathan U, et al. Antihyperglycemic effect of syringic acid on attenuating the key enzymes of carbohydrate metabolism in experimental diabetic rats. Biomed Prev Nutr 2014;4:595–602.
  • Muthukumaran J, Srinivasan S, Venkatesan RS, et al. Syringic acid, a novel natural phenolic acid, normalizes hyperglycemia with special reference to glycoprotein components in experimental diabetic rats. JAD 2013;2:304–9.
  • Kwak SY, Noh JM, Lee S, et al. Effect of alpha-resorcylic acid–L-phenylalanine amide on collagen synthesis and matrix metalloproteinase expression in fibroblasts. Bioorg Med Chem Lett 2014;24:742–5.
  • Khadem S, Marles RJ. Monocyclic phenolic acids; hydroxy- and polyhydroxybenzoic acids: occurrence and recent bioactivity studies. Molecules 2010;15:7985–8005.
  • Verma S, Singh A, Mishra A. Gallic acid: molecular rival of cancer. Environ Toxicol Pharmacol 2013;35:473–85.
  • Cerelli MJ, Curtis DL, Dunn JP, et al. Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids. J Med Chem 1986;29:2347–51.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–51.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–5.
  • Ekinci D, Beydemir S, Alim Z. Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II. Pharmacol Rep 2007;59:580–7.
  • Kato A, Yasuko H, Goto H, et al. Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity. Phytomedicine 2009;16:258–61.
  • Ziegler D. Polyneuropathy in the diabetic patient-update on pathogenesis and management. Nephrol Dial Transplant 2004;19:2170–5.
  • Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database Syst Rev 2007;4:CD004572.
  • Wermuth B, Bürgisser H, Bohren K, et al. Purification and characterization of human-brain aldose reductase. Eur J Biochem 1982;127:279–84.
  • Das B, Srivastava SK. Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte. Arch Biochem Biophys 1985;238:670–9.
  • Vander JDL, Stangebye LA, Hunsaker LA, et al. Purification of aldose reductase from human placenta and stabilization of the inhibitor binding site. Biochem Pharmacol 1988;37:1051–6.
  • Moeckel G, Hallbach J, Guder WG. Purification of human and rat kidney aldose reductase. Enzyme Protein 1994;48:45–50.
  • Sawada H, Hamatake M, Hara A, et al. Inhibition of human placenta aldose reductase by tannic acid. Chem Pharm Bull 1989;37:1662–4.
  • Kim CS, Kim J, Lee YM, et al. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats. Arch Pharm Res 2011;34:847–52.
  • Lin CY, Tsai SJ, Huang CS, et al. Antiglycative Effects of protocatechuic acid in the kidneys of diabetic mice. J Agric Food Chem 2011;59:5117–24.